Science Recorder |
Risk of heart failure increases in men who sit for long periods of time
Science Recorder According to a January 21 news release from the American Heart Association (AHA), the risk of heart failure in men – even in men who exercise regularly – increases with sitting for long periods of time. The results of the research appear in the AHA … |
|
Heart Cells Power This Swimming, Sperm-Like Bio-Bot
Gizmodo India Say what you will about these sperm-like bio-bots; they’ve got heart. The beating of live heart cells propels a tail back and forth, so that these self-powered swimming bio-bots-the first of their kind-could one day wriggle through your body delivering … |
MedscapeIdelalisib and rituximab extends survival in CLL patientsThe Oncology Report… rituximab extends survival in CLL patients. Adding idelalisib to rituximab significantly extends survival in patients with heavily pretreated relapsed chronic lymph…
Idelalisib Shows Efficacy in Relapsed CLL and LymphomaMedscapeThis trial showed that idelalisib used in combination with rituximab (Rituxan, Genentech/Roche) offered an option for patients with relapsed CLL who were unable to tolerate chemotherapy. The…
|
Luis Collazo dedicates fight to LI girl
Newsday Genatt met Collazo through her trainers Scooter Honig and Eddie O’Boyle at Competitive Edge Athletics in Port Washington when she was preparing for kidney transplant surgery in 2010. Genatt speaks at meetings of Nephrologists and organizes fundraising … |
Illumina, LabCorp Ink Multi-Year Deal – Analyst BlogNASDAQLast week, ILMN announced plans to enter emerging markets in mid-2014 by launching a human leukocyte antigen (HLA) typing product, developed using its NGS platform. The HLA typing assays that LH…
MedPage TodayRheuminations: 2013 Year in ReviewMedPage TodayHowever, by the end of 2013 we now have many comparator trials that show after failing an initial TNF inhibitor, there is equivalent or better efficacy when targeting different mechanisms with…
|
Illumina Sketches Strategy to Push NGS into Reproductive Health, Disease …
GenomeWeb HLA typing represents another $300 million market opportunity, according to the company. Illumina has already started to penetrate some of these new markets, as evidenced by a shift in its customer base. Over the last five years, Illumina’s revenue … |
TheAlternativePress.com |
Health Care Industry Professional with Personal Connection to Organ Donation …
TheAlternativePress.com Cheryl Cohen, a Chesterfield, NJ resident and healthcare industry professional with more than 25 years of experience, has a personal and long-standing connection to organ and tissue donation. “Eight years ago, my brother had a heart transplant,” said … |
Bioresorbable Scaffold Designed for PAD Yields Good Early ResultsTCTMDAll patients were treated with the Esprit everolimus-eluting BVS (Abbott Vascular, Santa Clara, CA), which is designed to fully metabolize within 18 months of implantation. Acute pro…